Fund Holdings — Qiming U.S. Ventures Management, LLC

Total Portfolio Value:
$55.64M
Total Bought:
$0
Total Sold:
$1.62M
Net Transaction:
-$1.62M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Tourmaline Bio Inc741,691741,6910$11.86M$35.48M63.76%+$23.62M
Korro Bio, Inc.(KRRO)368,085368,0850$4.60M$17.63M31.68%+$13.03M
Jasper Therapeutics, Inc.(JSPR)928,964928,9640$5.16M$2.21M3.97%-$2.94M
Kezar Life Sciences Inc
COM NEW
82,87182,8710$379.5K$323.2K0.58%-$56.4K
Hillevax Inc372,6150-372,615$741.5K$0—-$741.5K
Ventyx Biosciences Inc412,2250-412,225$882.2K$0—-$882.2K
Page 1 of 1
Qiming U.S. Ventures Management, LLC — 13F Holdings — Q3 2025 | TickerTrail